Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Lilly Plans New Chemistry Labs
by Michael McCoy
November 9, 2015
| A version of this story appeared in
Volume 93, Issue 44
Eli Lilly & Co. will spend $70 million to build a 130,000-sq-ft small-molecule drug discovery lab at its headquarters site in Indianapolis. When completed in 2017, the labs will bring all 200 of the firm’s Indianapolis-based small-molecule scientists under one roof. Today they are scattered among three buildings. The new labs will enable organic chemists and engineers to work side by side with modeling, analytical, and formulation scientists, Lilly says. Small molecules make up about half of Lilly’s drug pipeline.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter